Table 2.
Amblyopic eyes (n = 32) | Control eyes (n = 38) | Fellow eyes (n = 32) | p-valuea | p-valueb | p-valuec | p-valued | |
---|---|---|---|---|---|---|---|
CT nasal, μm, mean ± SD | 314.9 ± 55.4 | 286.2 ± 39.4 | 289.2 ± 59.3 | 0.023* | 0.013* | 0.837 | 0.023* |
CT subvfoveal, μm, mean ± SD | 338.9 ± 60.0 | 313.0 ± 42.1 | 315.31 ± 63.3 | 0.049* | 0.025* | 0.930 | 0.043* |
CT temporal, μm, mean ± SD | 317.1 ± 58.3 | 288.5 ± 44.6 | 292.1 ± 54.3 | 0.020* | 0.011* | 0.976 | 0.021* |
CV, mean ± SD | 0.715 ± 0.020 | 0.700 ± 0.020 | 0.710 ± 0.024 | 0.001* | <0.001* | 0.006* | 0.511 |
CT: choroidal thickness; CV: choroidal vascularity; SD: standard deviation. aKruskal Wallis test between Amblyopic eyes, fellow eyes, and controls. bMann-Whitney test between amblyopic eyes and controls. cMann-Whitney test between fellow eyes and controls. dMann-Whitney test between amblyopic eyes and fellow eyes. *Statistically significant p-value.